Alfacalcidol Increases the Therapeutic Efficacy of Ibandronate on Bone Mineral Density in Japanese Women with Primary Osteoporosis-Reference-Cited by-同舟云学术

Alfacalcidol Increases the Therapeutic Efficacy of Ibandronate on Bone Mineral Density in Japanese Women with Primary Osteoporosis

Published:2017 Issue:4 Volume:241 Page:319-326
ISSN:0040-8727
Container-title:The Tohoku Journal of Experimental Medicine
language:en
Short-container-title:Tohoku J. Exp. Med.

Author:

Nakamura Yukio¹²,Suzuki Takako¹,Kamimura Mikio³,Ikegami Shota¹,Uchiyama Shigeharu¹,Kato Hiroyuki¹

Affiliation:

1. Department of Orthopaedic Surgery, Shinshu University School of Medicine

2. Department of Orthopedic Surgery, Showa-Inan General Hospital

3. Center of Osteoporosis and Spinal Disorders, Kamimura Orthopedic Clinic

Publisher

Tohoku University Medical Press

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.jstage.jst.go.jp/article/tjem/241/4/241_319/_pdf

Reference23 articles.

1. Bouillon, R., Okamura, W.H. & Norman, A.W. (1995) Structure-function relationships in the vitamin D endocrine system. Endocr. Rev., 16, 200-257.

2. Chesnut, C.H. 3rd., Skag, A., Christiansen, C., Recker, R., Stakkestad, J.A., Hoiseth, A., Felsenberg, D., Huss, H., Gilbride, J., Schimmer, R.C. & Delmas, P.D.; Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe (BONE) (2004) Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J. Bone Miner. Res., 19, 1241-1249.

3. Christiansen, C. (1993) Skeletal osteoporosis. J. Bone Miner. Res., 8 Suppl 2, S475-480.

4. DeLuca, H.F. (2004) Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr., 80 (6 Suppl), 1689S-1696S.

5. Eisman, J.A., Civitelli, R., Adami, S., Czerwinski, E., Recknor, C., Prince, R., Reginster, J.Y., Zaidi, M., Felsenberg, D., Hughes, C., Mairon, N., Masanauskaite, D., Reid, D.M., Delmas, P.D. & Recker, R.R. (2008) Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study. J. Rheumatol., 35, 488-497.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential Use of Vitamin D3 and Phytochemicals for Their Anti-Ageing Effects;International Journal of Molecular Sciences;2024-02-09

2. Efficacy of the combination of Tenghuangjiangu tablets, alfacalcidol capsules and caltrate D3 tablets in osteoporotic vertebral compression fracture, and their effects on bone metabolic indices;Tropical Journal of Pharmaceutical Research;2022-11-03

3. Treatment of aseptic necrosis of the femoral head. Clinical guidelines;Rheumatology Science and Practice;2021-01-14

4. Effects of monthly minodronate with or without eldecalcitol addition in osteoporosis patients with rheumatoid arthritis: An 18-month prospective study;Osteoporosis and Sarcopenia;2019-12

5. Additive effects of eldecalcitol in poorly responding long-term bisphosphonate treatment for osteoporosis;Osteoporosis and Sarcopenia;2019-06